Article
Clinical Trial Watch: Bladder Cancer; Overactive Bladder
This list of National Institutes of Health trials is derived from the NIH's database and includes phase III and IV bladder cancer trials and phase II overactive bladder trials. This list is current as of Sept. 15, 2011.
Bladder Cancer
■ Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer Sponsor(s): U.Z. Gasthuisberg
Identifier: NCT00729287
■ Quality of Life in Patients With Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553215
■ Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients Sponsor(s): Memorial Sloan-Kettering Cancer Center; New York Presbyterian Hospital; Weill Medical College of Cornell University
Identifier: NCT00974818
■ Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer Sponsor(s): University of Birmingham
Identifier: NCT00553566
■ Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Sponsor(s): Southwest Oncology Group; National Cancer Institute (NCI)
Identifier: NCT00445601
